# Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC

> **NCT02577627** · — · UNKNOWN · sponsor: **Optimata Ltd.** · enrollment: 5000 (estimated)

## Conditions studied

- Non-Small Cell Lung Cancer
- Small Cell Lung Cancer
- Prostate Cancer
- Breast Cancer
- Colon Cancer

## Interventions

- **DEVICE:** PrediCare

## Key facts

- **NCT ID:** NCT02577627
- **Lead sponsor:** Optimata Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09
- **Primary completion:** 2018-01
- **Final completion:** 2019-09
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2017-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02577627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02577627, "Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02577627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*